Published in Cytotherapy on January 01, 2001
International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood (1997) 20.41
Arabidopsis map kinase 4 negatively regulates systemic acquired resistance. Cell (2000) 5.49
Different requirements for EDS1 and NDR1 by disease resistance genes define at least two R gene-mediated signaling pathways in Arabidopsis. Proc Natl Acad Sci U S A (1998) 4.70
EDS1, an essential component of R gene-mediated disease resistance in Arabidopsis has homology to eukaryotic lipases. Proc Natl Acad Sci U S A (1999) 3.80
Arabidopsis thaliana PAD4 encodes a lipase-like gene that is important for salicylic acid signaling. Proc Natl Acad Sci U S A (1999) 3.59
Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review. Circulation (1996) 3.23
Pronounced intraspecific haplotype divergence at the RPP5 complex disease resistance locus of Arabidopsis. Plant Cell (1999) 3.18
Acquired benign bronchoesophageal fistula in an adult. J Thorac Cardiovasc Surg (1989) 3.14
Three genes of the Arabidopsis RPP1 complex resistance locus recognize distinct Peronospora parasitica avirulence determinants. Plant Cell (1998) 2.97
Direct interaction between the Arabidopsis disease resistance signaling proteins, EDS1 and PAD4. EMBO J (2001) 2.88
Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95. Science (1996) 2.87
Definition of osteoarthritis of the knee for epidemiological studies. Ann Rheum Dis (1993) 2.83
Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer. J Natl Cancer Inst (1998) 2.67
Rapid diagnosis of cytomegalovirus infection in immunocompromised patients by detection of early antigen fluorescent foci. Lancet (1984) 2.65
Interplay of signaling pathways in plant disease resistance. Trends Genet (2000) 2.60
Efficacy of fish oil concentrate in the treatment of rheumatoid arthritis. J Rheumatol (2000) 2.48
Central nervous system relapse in acute promyelocytic leukaemia in patients treated with all-trans retinoic acid. Br J Haematol (1997) 2.27
HTLV-I screening in Britain. BMJ (1995) 2.25
Evaluation of mental retardation: recommendations of a Consensus Conference: American College of Medical Genetics. Am J Med Genet (1997) 2.19
Classical pituitary apoplexy: clinical features, management and outcome. Clin Endocrinol (Oxf) (1999) 2.15
Toxoplasmosis in bone marrow transplantation: a report of two cases and systematic review of the literature. Bone Marrow Transplant (2002) 2.09
Ketoconazole versus nystatin plus amphotericin B for fungal prophylaxis in severely immunocompromised patients. Lancet (1982) 2.01
Parenteral acyclovir therapy for herpesvirus infections in man. Lancet (1979) 1.99
Lactic acidosis and hypoglycaemia in children with severe malaria: pathophysiological and prognostic significance. Trans R Soc Trop Med Hyg (1994) 1.96
A laboratory comparison of T cell depletion by CD34+ cell immunoaffinity selection and in vitro Campath-1M treatment: clinical implications for bone marrow transplantation and donor leukocyte therapy. Bone Marrow Transplant (1997) 1.96
In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation. Blood (2000) 1.93
Cis-acting sequences regulating expression of the human alpha-globin cluster lie within constitutively open chromatin. Cell (1992) 1.92
The disease resistance signaling components EDS1 and PAD4 are essential regulators of the cell death pathway controlled by LSD1 in Arabidopsis. Plant Cell (2001) 1.92
Significantly improved PCR-based clonality testing in B-cell malignancies by use of multiple immunoglobulin gene targets. Report of the BIOMED-2 Concerted Action BHM4-CT98-3936. Leukemia (2006) 1.88
Proposed diagnostic criteria for apathy in Alzheimer's disease and other neuropsychiatric disorders. Eur Psychiatry (2009) 1.86
The CED-3/ICE-like protease Mch2 is activated during apoptosis and cleaves the death substrate lamin A. J Biol Chem (1996) 1.84
Apolipoprotein E4 and Alzheimer's disease pathology in Lewy body disease and in other beta-amyloid-forming diseases. Lancet (1994) 1.78
Should HLA-identical sibling bone marrow transplants for leukemia be restricted to large centers? Blood (1992) 1.77
Immunological analysis of the skin in graft versus host disease. Clin Exp Immunol (1982) 1.76
Educational attainment in long-term survivors of childhood acute lymphoblastic leukemia. JAMA (1994) 1.76
Cytogenetics adds independent prognostic information in adults with acute lymphoblastic leukaemia on MRC trial UKALL XA. MRC Adult Leukaemia Working Party. Br J Haematol (1997) 1.72
Hypoparathyroidism and hypocalcaemia during treatment for acute leukaemia. Br Med J (Clin Res Ed) (1982) 1.72
Healing of broken human chromosomes by the addition of telomeric repeats. Am J Hum Genet (1994) 1.69
Late effects of therapy in adult survivors of osteosarcoma and Ewing's sarcoma. Med Pediatr Oncol (1992) 1.67
A randomized controlled trial of itraconazole versus fluconazole for the prevention of fungal infections in patients with haematological malignancies. U.K. Multicentre Antifungal Prophylaxis Study Group. Br J Haematol (1999) 1.66
Powerful strategy for polymerase chain reaction-based clonality assessment in T-cell malignancies Report of the BIOMED-2 Concerted Action BHM4 CT98-3936. Leukemia (2006) 1.62
Repression of transcriptional activity at a distance by the evolutionarily conserved KRAB domain present in a subfamily of zinc finger proteins. Nucleic Acids Res (1994) 1.60
The prevalence of the activating JAK2 tyrosine kinase mutation in chronic porto-splenomesenteric venous thrombosis. Aliment Pharmacol Ther (2010) 1.60
Dorsal free graft urethroplasty for urethral stricture by ventral sagittal urethrotomy approach. Urology (2001) 1.60
EuroClonality/BIOMED-2 guidelines for interpretation and reporting of Ig/TCR clonality testing in suspected lymphoproliferations. Leukemia (2012) 1.60
Cervix cancer control in Louisville, Kentucky. Cancer (1970) 1.59
Malignant neoplasms in long-term survivors of bone marrow transplantation. Late Effects Working Party of the European Cooperative Group for Blood and Marrow Transplantation and the European Late Effect Project Group. Ann Intern Med (1999) 1.59
A 5 days primaquine regimen as anti-relapse therapy for Plasmodium vivax. Trans R Soc Trop Med Hyg (1998) 1.59
Spectrum of clinical presentation, treatment and prognosis in a series of eight patients with leukaemia cutis. Clin Exp Dermatol (2006) 1.58
Longitudinal fluctuations in cytomegalovirus load in bone marrow transplant patients: relationship between peak virus load, donor/recipient serostatus, acute GVHD and CMV disease. Bone Marrow Transplant (1998) 1.58
Impact of arterial surgery and balloon angioplasty on amputation: a population-based study of 1155 procedures between 1973 and 1992. J Vasc Surg (1997) 1.58
Use of anti-T-cell monoclonal antibody OKT3 to prevent acute graft-versus-host disease in allogeneic bone-marrow transplantation for acute leukaemia. Lancet (1982) 1.55
ETV6/AML1 fusion by FISH in adult acute lymphoblastic leukemia. Leukemia (2002) 1.54
Clonal gammopathies following alemtuzumab-based reduced intensity conditioning haematopoietic stem cell transplantation: association with chronic graft-versus-host disease and improved overall survival. Bone Marrow Transplant (2007) 1.53
Problematic WHO reclassification of myelodysplastic syndromes. Members of the International MDS Study Group. J Clin Oncol (2000) 1.53
Virus and immune responses: lymphocytic choriomeningitis virus as a prototype model of viral pathogenesis. Br Med Bull (1985) 1.52
Depletion of T lymphocytes in donor marrow prevents significant graft-versus-host disease in matched allogeneic leukaemic marrow transplant recipients. Lancet (1984) 1.51
Constitutive disease resistance requires EDS1 in the Arabidopsis mutants cpr1 and cpr6 and is partially EDS1-dependent in cpr5. Plant J (2001) 1.50
Liposomal amphotericin B (AmBisome): safety data from a phase II/III clinical trial. J Antimicrob Chemother (1991) 1.50
Stem cell mobilization in resistant or relapsed lymphoma: superior yield of progenitor cells following a salvage regimen comprising ifosphamide, etoposide and epirubicin compared to intermediate-dose cyclophosphamide. Br J Haematol (1997) 1.48
Response to imatinib in patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemia. Leukemia (2003) 1.47
The role of apoptosis, proliferation, and the Bcl-2-related proteins in the myelodysplastic syndromes and acute myeloid leukemia secondary to MDS. Blood (2000) 1.46
Fatal donor-derived Epstein-Barr virus-associated post-transplant lymphoproliferative disorder following reduced intensity volunteer-unrelated bone marrow transplant for myelodysplastic syndrome. Bone Marrow Transplant (2002) 1.46
Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor) Blood (1995) 1.43
Intensive treatment of renal failure in patients with myeloma. Clin Lab Haematol (1994) 1.43
Late onset immune pancytopenia following bone marrow transplantation. Br J Haematol (1991) 1.42
Pulmonary effect of inhaled furosemide in ventilated infants with severe bronchopulmonary dysplasia. Pediatrics (1997) 1.42
Determinants of mortality after myocardial infarction in patients with advanced renal dysfunction. Am J Kidney Dis (2001) 1.42
The case against HIV antibody testing of refugees and immigrants. CMAJ (1990) 1.40
Transmyocardial CO(2) laser revascularization improves symptoms, function, and quality of life: 12-month results from a randomized controlled trial. Am J Med (2001) 1.40
Economic evaluation of peripheral blood stem cell transplantation for lymphoma. Lancet (1992) 1.40
Stomatococcus mucilaginosus: an emerging pathogen in neutropenic patients. Clin Infect Dis (1992) 1.39
Direct visualization of cytomegalovirus-specific T-cell reconstitution after allogeneic stem cell transplantation. Blood (2001) 1.38
Alemtuzumab based reduced intensity conditioning allogeneic haematopoietic stem cell transplantation for myelofibrosis. Leuk Res (2011) 1.38
Ten years of AIDS. CMAJ (1992) 1.38
Receptive fields and response properties of mechanoreceptor neurons innervating siphon skin and mantle shelf in Aplysia. J Neurophysiol (1974) 1.37
Acyclovir prophylaxis against herpes virus infections in severely immunocompromised patients: randomised double blind trial. Br Med J (Clin Res Ed) (1983) 1.37
Factors affecting reconstitution of the T cell compartment in allogeneic haematopoietic cell transplant recipients. Bone Marrow Transplant (2003) 1.37
Comparison of preparative regimens in transplants for children with acute lymphoblastic leukemia. J Clin Oncol (2000) 1.36
Progress in allogenic bone marrow and peripheral blood stem cell transplantation for multiple myeloma: a comparison between transplants performed 1983--93 and 1994--8 at European Group for Blood and Marrow Transplantation centres. Br J Haematol (2001) 1.36
Colon cancer stem cells. Gut (2008) 1.35
Death during adulthood in survivors of childhood and adolescent cancer. Cancer (1994) 1.35
T cell subpopulations, monoclonal antibodies and their therapeutic applications. Clin Haematol (1982) 1.34
Prolonged access to the venous system using the Hickman right atrial catheter. Ann R Coll Surg Engl (1983) 1.34
Quality of life in long-term survivors of CNS tumors of childhood and adolescence. J Clin Oncol (1991) 1.33
Allogeneic bone marrow transplantation vs filgrastim-mobilised peripheral blood progenitor cell transplantation in patients with early leukaemia: first results of a randomised multicentre trial of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant (1998) 1.30
Four Arabidopsis RPP loci controlling resistance to the Noco2 isolate of Peronospora parasitica map to regions known to contain other RPP recognition specificities. Mol Plant Microbe Interact (1996) 1.29
Diverging effects of HLA-DPB1 matching status on outcome following unrelated donor transplantation depending on disease stage and the degree of matching for other HLA alleles. Leukemia (2009) 1.29
Transfer of a functioning humoral immune system in transplantation of T-lymphocyte-depleted bone marrow. Lancet (1986) 1.29
Remission induction with adenosine-deaminase inhibitor 2'-deoxycoformycin in Thy-lymphoblastic leukaemia. Lancet (1980) 1.29
Streptococcus mitis and ARDS in neutropenic patients. Lancet (1991) 1.28
Treatment of Erdheim-Chester disease with cladribine: a rational approach. Br J Ophthalmol (2004) 1.25
T cell regeneration after allogeneic bone marrow transplantation. Clin Exp Immunol (1983) 1.24
Peripheral blood stem cells as an alternative to marrow for allogeneic transplantation. Lancet (1993) 1.24